5 July 2017 - Nearly two weeks on from the release of the Interim Report of the Pharmacy Remuneration and Regulation Review and after being briefed by the Panel, the Pharmacy Guild remains very concerned about the Review's true intentions for the future of community pharmacy.

There is no doubt this review is causing uncertainty in the sector and nowhere is this more evident than in relation to dispensing, the core clinical function of any community pharmacy.

The Interim Report acknowledges the Treasury advice that "the most profitable pharmacies are only earning normal rates of returns on their investments" and then proceeds to suggest a total dispensing remuneration benchmark of $9.00 to $11.50 and to model a flat $10 per script dispensing fee, that would replace all current dispensing related fees (other than the Extemporaneously Prepared Fee).

Read Pharmacy Guild Viewpoint